Aim: To evaluate the efficacy of Khanda Pippali Avaleha in the management of Amlapitta 2 and to compare the efficacy of Khanda Pippali Avaleha with a standard drug. Materials and Methods: A total of 30 clinically diagnosed patients were selected from OPD/IPD of Panchakarma, Department of Rishikul Campus, Haridwar, and randomly categorized into two equal group. In Group A, Khanda Pippali Avaleha was administered orally in a dose of 10 g. Period of the study was for 60 days along with follow-up after 1 month. In control group, omeprazole was given in the dose 20 mg once a day for 60 days empty stomach. The assessment was done on the basis of classical symptomology of Amlapitta. Results and Discussion: Obtained results were analyzed statistically, and significance of results was evaluated (GraphPad InStat 3.10). Interventions were found to be significantly effective in reducing Daha, Amlodgara, Shula, Chhardi, and Avipaka and associated symptoms with P < 0.001, more percentage relief was found in Daha, Amlodgara, and Shula in patients treated with the standard drug. After 1 month of treatment, more sustained response was observed in patients treated with Khanda Pippali Avaleha. In Group A, only 7.69% show relapse to moderate improvement after having marked improvement. In Group B, 16.66% show relapse from marked to mild improvement. Conclusion: A small attempt has been made to prove Khanda Pippali Avaleha is quite promising and efficacious treatment; its efficacy can be better interpreted by conducting a clinical trial on large sample.
INTRODUCTION

I
n the 21 st century, the era of competition life it is full with stress having more speed and accuracy are the prime demands. The needs of the human being are infinite, but the availability is less to fulfill the growing needs which have no end. Nowadays, the people are attracted toward the junk food; they are changing their diet pattern, lifestyle, and behavioral pattern working with stress and strain. Hence, the people are becoming more stressful with worry, tension, and anxiety causing, so many psychological disorders which hamper the digestion and are causing hyperacidity, gastritis, dyspepsia, peptic ulcer disorders, and anorexia. All these pathological disorders covered under the broad umbrella of "Amlapitta" in Ayurveda.
It is very common disease encountering in present population with more or less severity. It is the one that which bears the direct impact of the dietic errors that a person indulges. 80% of the top 10 life-threatening diseases of the world are due to faults in dietary habits. [1] Gastrointestinal disturbances are increasing and India is no exception to this. Among them, nonulcer dyspepsia, a gastrointestinal tract disorder, acquires majority of the share. [2] Amlapitta is a burning problem of today's society. This has given rise to many other serious diseases. Amlapitta is the most important difficult disorder due to faulty lifestyle. [3] It is characterized by acid regurgitation, nausea, heartburn indicating the Vikruti of Pachakapitta along with Kledaka Kapha and Samana Vayu. [4] Although there are many antacids, proton pump inhibitor (PPI) is popular and available in pharmaceutical market. In spite of this remedies from medicinal plants are used to treat this disease successfully. Plant drugs and herbal
ORIGINAL ARTICLE
formulations are frequently considered to be less toxic and free from side effects than synthetic one. The US Food and the Drug Administration warned that there is increased the risk of fractures with the use of PPIs including esomeprazole, omeprazole, and pantoprazole. [5] Looking into the above-mentioned facts, this study has been taken and there is a need for treatment which can prevent the complication of the disease, safer, cost-effective, and easily available as well as reduce the recurrence effectively. This has encouraged assessing the effect of ayurvedic palliative drug, i. 
MATERIALS AND METHODS
Khanda Pippali Avaleha has been selected for the treatment of Amlapitta which is a classical reference mentioned in the Yogratnakar Uttarardh Amlapitta Nidanam [ Table 1 ]. [6] Aims and objectives
The aim and objective of the study are: 1. To evaluate the efficacy of Khanda Pippali Avaleha in the management of Amlapitta 2. Compare the efficacy of Khanda Pippali Avaleha with standard drug.
Patients were selected on the basis of the presence of classical symptoms of Amlapitta from the OPD/IPD Department of Panchakarma, Rishikul Campus, Haridwar. The patients were randomly categorized into two equal groups irrespective of their gender, age, income status, etc. Routine hematological and stool examination had been carried out to rule out any other pathology and to exclude the organic disorders. Special research pro forma had been prepared and after detail history taking and examination, selected 30 patients were randomly categorized into two groups on the basis of inclusion and exclusion criteria.
Criteria for selection of patients
Inclusion criteria
1. Classical symptoms of Amlapitta as described in ayurvedic texts, viz., Hrid Kantha Daah (burning sensation in epigastric region), Aruchi (loss of appetite), Utklesha (Nausea), Tikta Amla Udgaar (acid 
Randomization and blinding
Patients were randomized in a 1:1 ratio. This is an open study.
The study protocol was reviewed and approved by an Institutional Review Board at the institution level. From patients, written informed consent was taken before entering into the study. The importance of them for adherence to the treatment, Pathya-Apathya associated with the disease, schedule for follow-up, dates for visits to hospital was issued.
Interventions
• Drug: Khanda Pippali Avaleha 
METHODOLOGY OF ADMINISTRATION OF STANDARD DRUG
Omeprazole was administered in Group B in the dose 20 mg once a day for 60 days empty stomach.
Follow-up
After the completion of the therapy, the patient was advised to visit OPD at an interval of 15 days for 1 month.
Criteria for examination and assessment
Parameters were employed for assessment of the impact of the treatment produced in respective groups. Sign and symptoms of Amlapitta were looked into for assessment.
• Burning sensation in epigastric region
OBSERVATION
Total 30 patients were registered. Out of 30 patients, 26 patients had completed the treatment in three groups and 4 patients discontinued the treatment [ Table 2 ].
A maximum number of patients were females, i.e., 53.33% and 50% of patients were males [ Table 3 ].
Out of 30 patients, 53.33% were of Mand Agni (diminished metabolic state), 46.66% were Visahma Agni (irregular metabolic state) [ Table 4 ]. Table 6 ].
RESULTS
Statistical analysis
The information gathered on the basis of above observations was subjected to statistical analysis using GraphPad InStat. Software Version 3.10. As the criteria selected for analysis were nonparametric, hence "Paired t-test" was applied for statistical improvement analysis in the clinical features of Amlapitta in single group and "unpaired t-test" for statistical status of intergroup differences of clinical features. The results were interpreted.
The obtained results were interpreted as:
• No improvement: P > 0.05
• Improvement: P < 0.05 • Significant: P < 0.01 • Highly significant: P < 0.001
Relief observed in Daha and Amlodgara were 79.31% and 86.36%, respectively. Relief in Shula was 62.5%. Statistically, it is significant. Relief in Chhardi and Avipaka were 80% and 64.28%, respectively. Statistically, it is significant. Relief in Aruchi 75 % and result is significant (P < 0.05). While relief in Utklesha is 100%; this shows that there is a complete improvement in this symptom observed. Result was statistically highly significant (P < 0.001) [ Table 7 ].
Relief in Adhmana was 81.81%, in Vibandha was 75%, and in Bhrama was 75%. All these results were significant. While relief in Klamais 66.66%, i.e., P < 0.001 this shows that it was extremely significant [ Table 8 ].
As shown in Table 9 , 96.42% relief was observed in Daha followed by 88.88% relief in Amlodgara. 72.27% change was observed in Shula followed by 58.33% relief in Chhardi.
There was 60% relief in Avipaka, whereas Aruchi was relieved by 78.57%. 69.23% relief was observed in Utklesha. Changes in Daha and Amlodgara were extremely significant (P < 0.001). Relief obtained in Shula and Chhardi was significant (P < 0.02). Effect of intervention on Aruchi and Utklesha was highly significant (P < 0.001), whereas results obtained in Avipaka were significant (P < 0.01).
Results obtained in Vibandha (constipation) were not significant statistically (P < 0.10). Results obtained on Bhrama (vertigo) were not statistically significant (P < 0.10) [ Table 10 ].
When comparison was drawn between Group A and Group B, Group B was found to be more effective in symptoms of Aruci, Shoola, Daha, respectively. However, these differences were found to be insignificant. Both groups were equally effective on providing relief from Amlodgara and Avipaka. Group A intervention was more effective in relieving Chhardiand Utklesha. However, the difference was found to be nonsignificant [Table 11 ].
When comparison was drawn between the Group A and Group B regarding the effect of treatment on the associated symptoms, the statistically significant difference was found to be insignificant. However, the intervention of Group A was found to be more significant in providind relief from all associated symptoms.
In Group A, only 7.69% (number = 1) patients showed relapse to moderate improvement after having marked improvement. One patient (7.69%) showed relapse to mild improvement after marked improvement. Rest 84.61% showed no increase in grading [ Table 13 ].
In Group B, all patients showed relapse after having complete remission from the intervention and another 16.66% (number = 2) showed relapse from marked to mild improvement, one patient showed relapse from moderate to mild improvement (8.33%). Two patients were found no improvement after 1 month of intervention. Rest 58.33% showed no increase in grading.
DISCUSSION Sex
In this study, maximum percentage of females were observed which approximate corresponds with data as per study conducted by B Benerson et al, Non-ulcer dyspepsia and peptic ulcer: the distribution in a population and their relation to risk factors observed the prevalence of non-ulcer dyspepsia more in females. The distribution in a population and their relation to risk factors observed the prevalence of nonulcer dyspepsia more in females. This study well correlates with above data. 53.33% patients who were female suffered from this disease because of their mental and physical stress, which is due to professional as well as personal responsibilities. Higher incidence in female is due to imbalance and irregularity in diet intake.
Agni
Nearly, 53.33% patients were having Mandagni [ Table 4 ], whereas 46.67% patients were having Vishamagni. Main causes for the disease are improper diet, not following AharaVidhiVisheshayatana, Viruddhahara, and Asatmyaahara which is the main factor of impaired digestive function, i.e., Mandagni. [2] Risk factor
About 33.33% patients are suffering from stress; 26.67% had history of consumption of NSAIDs [ Table 6 ]. NSAIDs are the most common cause of peptic ulcer disease in patients without Helicobacter pylori infection. Topical effects of NSAIDs induce submucosal erosions. In addition, by inhibiting cyclooxygenase, NSAIDs inhibit the formation of prostaglandins. [7] In a study conducted by Dr. Rafi Abul Siddique, the prevalence of acid peptic disease among the patients with abdominal pain -88.3% had stress, anxiety, or tension which supported our study.
[8]
Manasika Nidana
As per Table 5 , 43.33% of patients were having Soka (grief), 33.33% of patients were having Chinta (worry, tension). [9] Manasika Bhavas (psychological factor) cause Mandagni (diminished metabolism) and Ajirna (indigestion) which were responsible for the aggravation of the disease process. [10] Acid peptic disorder forms as a result of stress, a genetic predisposition to excessive stomach acid secretion and poor lifestyle habits. It was believed that such influence contributes to a build-up of stomach acids that erode the protective lining of the stomach. However, standard drug (omeprazole) was found to be quite effective in providing immediate relief from symptoms such as Daha, Amlodgara, and Shula (pain). However, during follow-up after 1 month, there is reduction in percentage relief and relapse of symptoms occurs while treatment with ayurvedic palliative medicine more sustained relief was found.
CONCLUSION
Khanda Pippali Avaleha was proved to be quite promising treatment of Amlapitta as that of the standard drug. After 1 month of treatment, more sustained response was observed in patients treated with Khanda Pippali Avaleha studying on repeated application of these treatment procedures may be conducted to evaluate further. For better and more accurate results, this study should be conducted on the large sample so that new ayurvedic palliative drug can be arised as a new ray of hope in the management of Amlapitta without any complications and side effects.
